Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies

Kirk R. Schultz(University of British Columbia), Geoff D.E. Cuvelier(CancerCare Manitoba), Michael A. Pulsipher(Primary Children's Hospital), Alexandra Cheerva(Kosair Children's Hospital), Kimberly A. Kasow(University of North Carolina at Chapel Hill), Süreyya Savaşan(Children's Hospital of Michigan), Andrew C. Harris(Primary Children's Hospital), Emi Caywood(Alfred I. duPont Hospital for Children), Michael Joyce, Eneida R. Nemecek(Oregon Health & Science University), Shima Azadpour, Anat Halevy(University of British Columbia), Tal Schechter(Hospital for Sick Children), Madeline Lauener(University of British Columbia), Sayeh Abdossamadi(University of British Columbia), Benjamin Oshrine(Johns Hopkins All Children's Hospital), Justin T. Wahlstrom(University of California, San Francisco), Victor Lewis(Alberta Children's Hospital), Ánita Lawitschka(St Anna Children's Hospital), Sung Won Choi(University of Michigan), Bernard Ng(Rush University Medical Center), Sara Mostafavi(Canadian Institute for Advanced Research), Peter Subrt(University of British Columbia), Amina Kariminia(University of Washington), Carrie L. Kitko(Vanderbilt University Medical Center), David A. Jacobsohn(Children's National), Sonali Chaudhury(Northwestern University), Anna Pawłowska(City of Hope), Joseph H. Chewning(Kettering University), David Mitchell(Montreal Children's Hospital), Elena Ostroumov(University of British Columbia), Henrique Bittencourt(Centre Hospitalier Universitaire Sainte-Justine), Monica Bhatia(Columbia University), Gail Megason(University of Mississippi Medical Center), Allyson Flower(New York Medical College), Donald W. Coulter(University of Nebraska Medical Center)
Blood
February 12, 2020
Cited by 67


Related Papers